Commercial Strategy

Reach More Patients with a Comprehensive Biopharma Commercial Strategy

You need a biopharma commercial strategy to get that product to the patients who need it–developing that strategy starts years before launch.

Your work is not done when your breakthrough therapy is approved.

Hit the right milestones at the right time in the right order to bring value to patients, healthcare providers, and payers. Our effective go-to-market strategies align your company’s vision with your biopharma asset’s commercial and clinical development plans.

Elements of Successful Commercial Strategy

commercial strategy elements include Brand Strategy, Commercialization and Launch Readiness Assessments, Go-to-Market Planning, Launch Plan Development and Management , Lifecycle Management, Value Proposition Development

Your Custom Biopharma Commercial Strategy

We understand what’s at stake when you release a new biopharma product.

We know exactly how much time, effort, and resources are needed to bring a treatment to market, and we’re here to help you overcome obstacles and succeed.

That’s why we don’t take your brand strategy lightly. We are committed to being good stewards of your resources and guiding you to market success.

We offer right-sized, fit-for-purpose solutions for your unique needs. As the project evolves, our adaptable support evolves with it, so you are never left to face challenges alone.

Adaptable Support
Case Study

Filling the Gaps in Commercial Planning Expertise

Biopharma company in Phase 3 clinical trials of a treatment for a rare form of muscular dystrophy.

Our client’s internal team had deep scientific knowledge but limited experience in bringing treatments to market.

The NemetzGroup was engaged to create a map of critical biopharma commercialization activities, along with budgets and priorities.

We worked with the client to develop a three-year strategy and budget for launching their product.

Throughout the process, we shared knowledge and built the company’s internal capabilities.

Without an internal go-to-market team, the client kept The NemetzGroup on to implement the strategy.

We became the acting go-to-market team, offering insights to inform key business decisions, executing high-priority tasks, and supporting communications.

We continued supporting the client as it built its first internal commercialization team.